Tectonic Therapeutic股票：竞争对手数据强化TX45看涨理由（纳斯达克：TECX）
· seekingalpha.com
Tectonic Therapeutic（TECX）：TX45的CpcPH-HFpEF试验设计、默克CADENCE研究支持、充裕现金跑道及2026–27年催化剂。详情请见此处。
I have a strong inclination towards high-growth companies, often treading in sectors poised for exponential expansion. My expertise lies in understanding and in...